ORLANDO, Fla.—Slowed drug launches and steadily climbing rates of prescription abandonment were among several key market trends to emerge from new IQVIA data released during the National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo 2022.
Compared with 2021, drug product launches have slowed down in 2022, with 33 new products coming to market by July 22 versus 50 launches for the same period last year, reported Doug Long, the vice president of industry